Which is the best place for a Mounjaro shot?

Is there a measurable difference in how Mounjaro is absorbed depending on where you inject?

Clinical pharmacology studies show that subcutaneous absorption of tirzepatide is broadly equivalent across the three licensed sites. The Mounjaro SmPC (available in full on the eMC) does not designate a preferred site for this reason. In practice, that equivalence is good news: it means you can choose the site that suits your routine and your build rather than feeling anxious about optimising for pharmacokinetics.

Where differences do emerge is not between sites in healthy tissue, but between healthy tissue and tissue that has been repeatedly injected in exactly the same spot. Lipohypertrophy (a firm, fatty thickening under the skin) develops when the same patch gets the needle week after week. Injecting into a hardened area slows absorption and can make doses less predictable. Rotation is therefore the most clinically meaningful 'site choice' you can make. Think of it less as picking a favourite and more as working through a rota.

If you find one site noticeably more comfortable than the others, that is fine as a preference, just ensure you are still moving around within that zone, giving each small patch several weeks' rest before returning to it. Our overview of Mounjaro injection sites goes into the rotation pattern in more detail.

What makes the abdomen the site most people start with?

The abdomen is the site most people reach for first, and there are practical reasons for that. It is easy to see, straightforward to pinch into a fold if needed, and most people can manage it comfortably on their own. The target zone runs roughly 5 cm either side of the navel (but not the navel itself) and extends down towards the lower belly. Avoid any area with visible veins, scar tissue, or skin that looks or feels different from the surrounding tissue.

One thing worth knowing: tight waistbands or clothing worn immediately after an abdominal injection are not a clinical concern, but some people find looser clothing more comfortable for an hour or so afterwards. Similarly, there is no evidence that eating or drinking around the time of the injection changes absorption in the way that it does with oral semaglutide tablets. If you are unsure whether what you are eating alongside treatment is working for you, our guide on nutrition alongside Mounjaro covers the basics.

The abdomen also tends to be the easiest site to keep consistently clean and dry, an important practical detail. Alcohol swabs are commonly used to clean the area before injecting; let the skin dry fully before inserting the needle to avoid a stinging sensation.

When might the thigh or upper arm suit you better?

The front and outer thigh is a useful alternative, particularly for people who find the abdomen uncomfortable during the first few weeks of treatment when nausea can be more pronounced. It is also the go-to site for anyone who prefers to inject sitting down, the pen clicks in cleanly against a relaxed thigh muscle. Aim for the middle third of the outer thigh rather than the inner surface or the area directly over the knee.

The outer upper arm is licensed but involves a practical limitation: self-injection requires a bit of flexibility, and some people find it difficult to hold the pen firmly enough at the right angle without help. If you are self-injecting into the upper arm, a mirror and a steady surface to brace against can help. If a partner or carer is helping with injections, the upper arm is often easiest for them to access.

Timing your injection consistently, whether that is Saturday morning or a Tuesday evening after work, helps build the habit regardless of which site you use. Our guide on the best time to take Mounjaro explores how timing interacts with side effects and routine. And if you are comparing Mounjaro to other emerging treatments, this comparison with retatrutide explains where the evidence stands.

What injection-site reactions are normal, and when should you speak to someone?

Mild redness, slight swelling or a small bruise at the injection site after using the Mounjaro KwikPen is common and listed in the prescribing information. These reactions usually fade within two to three days and are not a reason to stop treatment. They are more likely in the first few weeks as your skin adjusts, and tend to reduce with better technique, holding the pen firmly against the skin for the full duration of the injection, not lifting it too early.

A few things are worth reporting promptly to your prescriber. A firm lump under the skin that persists for more than a week or two suggests lipohypertrophy; the fix is straightforward (change the spot) but you should flag it so your rotation pattern can be reviewed. Significant swelling, warmth, spreading redness or pain that worsens over days rather than easing is not a typical injection-site reaction and should be assessed by a clinician. The same applies if you notice a reaction that looks like an allergic response, hives, itching spreading beyond the injection site, or any difficulty breathing.

The MHRA Yellow Card scheme lets patients report any suspected side effects directly to the regulator, and doing so contributes to ongoing safety monitoring for medicines like Mounjaro that are still under additional surveillance. If you have questions about how your skin is responding, the prescribers and support team at nume are available seven days a week. When you are ready to discuss your eligibility, if you want to understand where to find the best place for Mounjaro before getting started, our prescribers will review your case the same day.